THERAVANCE BIOPHARMA,INC. (NASDAQ:TBPH) Files An 8-K Results of Operations and Financial ConditionItem 2.02. Results of Operations and Financial Condition.
On August8, 2017, Theravance Biopharma,Inc. issued a press release and is holding a conference call regarding its financial results for the quarter ended June30, 2017 and a business update. A copy of the press release is furnished as Exhibit99.1 to this Current Report and a copy of materials that will accompany the call is furnished as Exhibit99.2 to this Current Report.
The information in Item 2.02 and in Item 9.01 of this Current Report on Form8-K, including Exhibits 99.1 and 99.2, is being furnished and shall not be deemed “filed” for the purposes of Section18 of the Securities Exchange Act of 1934, as amended (the “Securities Exchange Act of 1934”), or otherwise subject to the liabilities of that Section, nor shall it be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, except as expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
99.1 Press Release dated August8, 2017
99.2 Materials Accompanying the Call